Oncology APIs & Oncology Drugs
Provider 
Founded 1972
Sells To Consumers, Hospitals
Pricing Model Product Sales
Ownership Private

Cristália's oncology-ingredients operation running Latin America's first high-potency oncology API plant, opened in 2019.
Cristália's oncology chemical-pharmaceutical operation inaugurated Latin America's first high-potency oncology active-ingredient plant in 2019, ending Brazil's previous full dependence on imported oncology inputs. It manufactures ingredients including zoledronic acid and abiraterone through a patented, safer temozolomide process registered in the United States, Israel, Mexico, China, India, and Europe.
The operation supplies the active ingredients for Cristália's finished oncology medicines and feeds the company's dedicated oncology finished-dose plant.
Eurofarma

Eurofarma Oncologia
eurofarma.com.br
MSD Brasil

MSD Oncologia (Brazil)
msd.com.br
Libbs Farmaceutica

Oncológicos
libbs.com.br
| Attribute | Oncology APIs & Oncology Drugs | Eurofarma Oncologia | MSD Oncologia (Brazil) | Oncológicos | |
|---|---|---|---|---|---|
| Provider | |||||
| Founded | 1972 | 1972 | — | 1958 | |
| Sells To | Consumers, Hospitals | Consumers | — | Consumers, Enterprise | |
| Pricing Model | Product Sales | Recurring, Software, Transactional | — | Recurring, Software | |
| Ownership | Private | Public | — | Private |
Provider 
Founded 1972
Sells To Consumers, Hospitals
Pricing Model Product Sales
Ownership Private
Provider 
Founded 1972
Sells To Consumers
Pricing Model Recurring, Software, Transactional
Ownership Public
Provider 
Founded —
Sells To —
Pricing Model —
Ownership —
Provider 
Founded 1958
Sells To Consumers, Enterprise
Pricing Model Recurring, Software
Ownership Private
Blau Farmacêutica's active-pharmaceutical-ingredient (IFA) production, including a dedicated high-complexity biotech raw-materials plant.


EMS's hospital unit supplying medicines and solutions to hospitals and institutional healthcare buyers, reinforced by a 2026 injectables acquisition.
Amgen oncology therapy-area portfolio spanning small molecules, T-cell engagers, and monoclonal antibodies.


Biopharma business unit of Fresenius Kabi Brasil offering biosimilar medicines in Brazil.


Prescription medicines from EMS for pharmacists, physicians and healthcare professionals across practically all medical specialties.
Blau Farmacêutica's active-pharmaceutical-ingredient (IFA) production, including a dedicated high-complexity biotech raw-materials plant.
EMS's hospital unit supplying medicines and solutions to hospitals and institutional healthcare buyers, reinforced by a 2026 injectables acquisition.

Amgen oncology therapy-area portfolio spanning small molecules, T-cell engagers, and monoclonal antibodies.
Biopharma business unit of Fresenius Kabi Brasil offering biosimilar medicines in Brazil.

Prescription medicines from EMS for pharmacists, physicians and healthcare professionals across practically all medical specialties.
